Gov. Hochul has indicated that while there is no immediate IV fluid shortage, the state is proactively preparing for potential challenges following Hurricane Helene, particularly in light of the closure of the Baxter plant in North Carolina, which supplies a substantial portion of the nation’s IV fluids. The state’s collaboration with local and federal officials is crucial for mobilizing additional supplies if necessary.
The Department of Health's guidance emphasizes the urgent need for hospitals and care providers to implement safety measures by delaying elective procedures to preserve existing IV fluid supplies, conserve inventory, and prioritize critical cases. This is part of a larger strategy as hospitals nationwide grapple with the implications of potential shortages.
Hospital groups are advocating for the FDA to explore options to alleviate the current supply chain challenges. This includes allowing institutions to produce their own IV fluids, seeking aid from international suppliers, extending shelf life for existing stocks, and invoking the Defense Production Act to ensure the prioritization of IV fluid manufacturing.
With the situation remaining fluid due to ongoing weather events and manufacturing plant conditions, the state is monitoring closely for any further complications, especially from the approaching Hurricane Milton. Fortunately, the second plant operates in Florida and is poised to increase production once it is safe.
Collection
[
|
...
]